Peter Kies - 11 Mar 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role: CFO
Signature: Peter Kies
Issuer symbol: INO
Transactions as of: 11 Mar 2022
Net transactions value: -$101,140
Form type: 4
Filing time: 14 Mar 2022, 16:29:41 UTC
Previous filing: 09 Mar 2022
Next filing: 28 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INO	Common Stock	Options Exercise		+59,737	+40%		210,694	11 Mar 2022	Direct	F1
transaction	INO	Common Stock	Tax liability	$101,140	-31,410	-15%	$3.22^*	179,284	11 Mar 2022	Direct	F2
holding	INO	Common Stock						4,500	11 Mar 2022	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-59,737	-50%	$0.000000	59,737	11 Mar 2022	Common Stock	59,737		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2	The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.